Orthofix Medical (OFIX) Asset Writedowns and Impairment (2010 - 2019)

Orthofix Medical has disclosed Asset Writedowns and Impairment across 9 years of filings, most recently posting $1.0 million for Q4 2019.

• Quarterly Asset Writedowns and Impairment rose 3778.57% year-over-year to $1.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $1.9 million (up 415.69% YoY) and the FY2022 annual result came in at $2.1 million, up 371.85% from the prior year.
• Asset Writedowns and Impairment climbed to $1.0 million in Q4 2019, from $223000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $4.8 million in Q3 2017 and troughed at -$3.9 million in Q4 2017.
• A 4-year average of $253000.0 and a median of $162500.0 in 2016 frame the typical range for Asset Writedowns and Impairment.
• Biggest YoY gain for Asset Writedowns and Impairment was 4571.57% in 2017; the steepest drop was 6903.45% in 2017.
• Tracing OFIX's Asset Writedowns and Impairment over 4 years: stood at $58000.0 in 2016, then tumbled by 6903.45% to -$3.9 million in 2017, then soared by 99.29% to -$28000.0 in 2018, then surged by 3778.57% to $1.0 million in 2019.
• Business Quant data shows OFIX's Asset Writedowns and Impairment at $1.0 million in Q4 2019, $223000.0 in Q3 2019, and $592000.0 in Q2 2019.